GeneNews Posts Drop in Q4 Revenues, Preps for Q3 Launch of ColonSentry Test | GenomeWeb
 
NEW YORK (GenomeWeb News) – GeneNews this week reported a 57 percent drop in revenues for the fourth quarter of 2007 and said it expects to launch its ColonSentry colon cancer diagnostic through its in-house clinical reference lab in the third quarter.
 
For the three months ended Dec. 31, 2007, Toronto-based GeneNews reported total revenue of CDN$300,000 (US$295,000), compared to CDN$700,000 (US$687,000) in the comparable period of 2006.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.